.
New Delhi, April 21 (MondayMirror.com) The expert panel of India’s apex drug regulator on Thursday recommended grant of emergency use authorisation to Covid vaccine Corbevax for those in the 5-12 years age bracket.
According to a source familiar with the development, the Subject Expert Committee has recommended Drug Controller General of India grant the emergency use authorisation to Hyderabad-based Biological E’s Corbevax for this age. However, the emergency use authorisation may be the subject of certain conditions, the source added.
Earlier in the day, the panel held a meeting to discuss the recommendations on restricted emergency use of Bharat Biotech’s Covaxin and Biological E’s Corbevax vaccines among children aged 5-12.
The SEC has sent the recommendations to the DCGI. After the DCGI’s nod to the recommendation, the Union Health Ministry may give final approval to begin the vaccination for this age group.
Corbevax vaccine is India’s first indigenously-developed protein sub-unit vaccine against Covid-19. This vaccine is currently being administered to children in the age group 12-14 years.
Source: IANS
Actress Ridhi Dogra, who is all set to step into “The 50”, says that she…
Actress Raveena Tandon is the latest Bollywood celeb to join the ongoing "2026 is the…
In recent days, a series of videos showing people bypassing subway fare gates in New…
and Bipasha Basu were hit by a massive wave of nostalgia as their song…
Actress Khushi Kapoor is clearly prioritising fitness and self-care as she steps into what she…
Tollywood star Allu Arjun was in Tokyo, Japan, to promote his blockbuster hit "Pushpa 2:…